SHAREHOLDER ALERT: Investigation of Intersect ENT Announced by Holzer & Holzer, LLC
ATLANTA--(BUSINESS WIRE)--May 7, 2019--Holzer & Holzer, LLC is investigating whether certain statements made by Intersect ENT, Inc. (“Intersect ENT” or the “Company”)(NASDAQ: XENT) complied with federal securities laws. On May 6, 2019, Intersect ENT reported a $10.8 million first quarter loss, lowered its 2019 guidance, and announced that its CEO will step down on June 5. The price of Intersect ENT’s stock fell following the announcement.
If you purchased shares of Intersect ENT and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at firstname.lastname@example.org or Marshall P. Dees, Esq. at email@example.com, or by toll-free telephone at (888) 508-6832 to discuss your legal rights.
Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190507005779/en/
CONTACT: Corey D. Holzer, Esq.
(888) 508-6832 (toll-free)
KEYWORD: UNITED STATES NORTH AMERICA GEORGIA
INDUSTRY KEYWORD: PROFESSIONAL SERVICES LEGAL
SOURCE: Holzer & Holzer, LLC
Copyright Business Wire 2019.
PUB: 05/07/2019 11:17 AM/DISC: 05/07/2019 11:17 AM